GOVX

GeoVax Labs, Inc. is a clinical-stage biotechnology firm based in Smyrna, Georgia, specializing in groundbreaking vaccines and immunotherapies targeting infectious diseases and cancers. The company leverages its proprietary modified vaccinia Ankara virus-like particle platform to propel a diverse pipeline of therapeutic candidates through various clinical trial phases. With a strong emphasis on fulfilling urgent medical needs and harnessing advanced vaccine technologies, GeoVax is strategically positioned as a key contributor in the immunotherapy landscape and the fight against infectious diseases, promising noteworthy advancements in public health and therapeutic solutions.